Concepts in receptor optimization: Targeting the RGD peptide

被引：0
|
作者：
Chen, Wei [1 ]
Chang, Chia-En [1 ,2 ]
Gilson, Michael K. [1 ]
机构：
[1] Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, 9600 Gudelsky Drive, Rockville, MD 20850, United States
[2] Department of Chemistry and Biochemistry, University of California, San Diego, San Diego, CA, United States
来源：
Journal of the American Chemical Society | 2006年 / 128卷 / 14期
关键词：
Synthetic receptors have a wide range of potential applications; but it has been difficult to design low molecular weight receptors that bind ligands with high; proteinlike affinities. This study uses novel computational methods to understand why it is hard to design a high-affinity receptor and to explore the limits of affinity; with the bioactive peptide RGD as a model ligand. The M2 modeling method is found to yield excellent agreement with experiment for a known RGD receptor and then is used to analyze a series of receptors generated in silico with a de novo design algorithm. Forces driving binding are found to be systematically opposed by proportionate repulsions due to desolvation and entropy. In particular; strong correlations are found between Coulombic attractions and the electrostatic desolvation penalty and between the mean energy change on binding and the cost in configurational entropy. These correlations help explain why it is hard to achieve high affinity. The change in surface area upon binding is found to correlate poorly with affinity within this series. Measures of receptor efficiency are formulated that summarize how effectively a receptor uses surface area; total energy; and Coulombic energy to achieve affinity. Analysis of the computed efficiencies suggests that a low molecular weight receptor can achieve proteinlike affinity. It is also found that macrocyclization of a receptor can; unexpectedly; increase the entropy cost of binding because the macrocyclic structure further restricts ligand motion. © 2006 American Chemical Society;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
收藏
页码：4675 / 4684
相关论文
共 50 条
  • [1] Concepts in receptor optimization: Targeting the peptide RGD
    Chen, Wei
    Chang, Chia En
    Gilson, Michael K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [2] Concepts in receptor optimization: Targeting the RGD peptide
    Chen, W
    Chang, CE
    Gilson, MK
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (14) : 4675 - 4684
  • [3] Binding and uptake of cyclic RGD-peptide as a receptor targeting to rat hepatic stellate cells
    Du, S
    Wang, J
    Lu, W
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 201A - 202A
  • [4] Tumor targeting with a monomeric, dimeric and tetrameric RGD peptide
    Dijkgraaf, I.
    Frielink, C.
    Kruytzer, J.
    Oyen, W. J. G.
    Liskamp, R.
    Corstens, F. H. M.
    Boerman, O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S150 - S150
  • [5] Liposomes modified with cyclic RGD peptide for tumor targeting
    Dubey, PK
    Mishra, V
    Jain, S
    Mahor, S
    Vyas, SP
    JOURNAL OF DRUG TARGETING, 2004, 12 (05) : 257 - 264
  • [6] Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor
    Jacquot, Guillaume
    Lecorche, Pascaline
    Malcor, Jean-Daniel
    Laurencin, Mathieu
    Smirnova, Maria
    Varini, Karine
    Malicet, Cedric
    Gassiot, Fanny
    Abouzid, Karima
    Faucon, Aude
    David, Marion
    Gaudin, Nicolas
    Masse, Maxime
    Ferracci, Geraldine
    Dive, Vincent
    Cisternino, Salvatore
    Khrestchatisky, Michel
    MOLECULAR PHARMACEUTICS, 2016, 13 (12) : 4094 - 4105
  • [7] RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions
    Javid, Hossein
    Oryani, Mahsa Akbari
    Rezagholinejad, Nastaran
    Esparham, Ali
    Tajaldini, Mahboubeh
    Karimi-Shahri, Mehdi
    CANCER MEDICINE, 2024, 13 (02):
  • [8] RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study
    Saket Asati
    Vikas Pandey
    Vandana Soni
    International Journal of Peptide Research and Therapeutics, 2019, 25 : 49 - 65
  • [9] Lu-177 Labeled RGD peptide for Tumor Targeting
    Hong, Y.
    Lee, S.
    Choi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S318 - S318
  • [10] RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study
    Asati, Saket
    Pandey, Vikas
    Soni, Vandana
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2019, 25 (01) : 49 - 65
12345